Exxon Mobil enters the week with a clean trend: short sellers are retreating, the Street is nudging targets higher, and the stock is up nearly 3% over five sessions to $154.88. The real story is how closely the analyst community is converging on the same direction — and what that says about where positioning sits ahead of the company's next earnings event on May 27.
Analyst activity has been notably constructive. UBS raised its target to $174 from $171 this week while reiterating Buy. RBC Capital maintained its $180 target. The more telling move came from JPMorgan earlier in the month, which lifted its price target sharply to $170 from $140 and held its Overweight rating — a signal that one of the Street's largest energy desks grew materially more confident after tariff volatility knocked crude prices around in April. BNP Paribas upgraded the stock outright. Morgan Stanley trimmed its target by just $1, keeping Overweight. The one dissent came from Wolfe Research, which downgraded to Peer Perform. But the overall direction of analyst travel is upward — the consensus mean price target now sits at $165.91, implying roughly 7% return potential from current levels. That is a modest premium, not a heroic bet.
The lending market is about as relaxed as it gets for a $637 billion company. Short interest is just over 1% of the free float — a level so low it barely registers as a meaningful signal on its own. What is notable is the direction: shorts peaked above 1.17% of the float in early April, when macro uncertainty around tariffs was at its worst, and have since fallen back to roughly 1.04% as of May 5. Borrow costs track that retreat — the cost to borrow has dropped 21% over the week to 0.33% annualised, one of the cheapest borrow rates in the energy complex. Availability remains extremely loose. There is simply no evidence of a crowded short position here, no squeeze pressure, and no meaningful demand for new borrows.
Options confirm the same relaxed tone. The put/call ratio of 0.67 tracks almost exactly in line with its 20-day average of 0.65 — a z-score of just 0.34 — indicating that options traders are neither hedging aggressively nor loading up on calls. The reading sits comfortably in the middle of the past year's 0.47–0.90 range. RSI at 53 is equally neutral. There is no options-market tension to speak of ahead of the May 27 print.
The valuation picture shows some compression over the past month: the P/E has eased to 14.8x — down nearly 3 points over 30 days — and price-to-book has pulled back to 2.3x. The EV/EBITDA multiple, at 7.8x, has also drifted lower over the month. Bulls point to the company's refining scale and diversified commodity exposure, plus its deepening position in carbon capture as an incremental growth lever. Bears flag a tough chemicals margin environment and the observation that much of the Guyana and Permian growth is already in the price. The dividend score ranks in the 66th percentile, with a forward yield of 2.74% — not headline-grabbing but a steady floor for income-oriented holders.
Peer performance adds useful texture. Closest correlate CVX rose 2.3% on the week — in line with XOM. OVV and APA surged 7.9% and 7.3% respectively, suggesting smaller-cap energy names caught more of the bounce from stabilising crude prices. COP lagged, down 0.8% on the week. XOM's 2.9% weekly gain lands it squarely in the middle of the group — the large-cap defensive play in a sector week where investors showed some appetite for risk down the cap scale.
With earnings due May 27, the question on both sides of the desk is less about positioning — which is light — and more about where oil prices and chemical margins land between now and then.
See the live data behind this article on ORTEX.
Open XOM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
